Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail
-

Slides for the February 3, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee

Ellis F. Unger, M.D., Deputy Director, Division of Cardiovascular and Renal Products, Office of Drug Evaluation-I, Office of New Drugs, CDER, FDA [PDF]

Sponsor

Eli Lilly and Company Presentation and Backup Files [PDF] 

Open Public Hearing

OPH #2 [PDF] 

-
-